Skip to content
NEWSnet Hawaii
    • Homepage
Zepto Life Technology Receives FDA Breakthrough Device Designation for Targeted Liquid Biopsy Test for Invasive Mold Infections

Author: Zepto Life Technology

Posted Date:

June 3, 2026
  • Zepto Life Technology Receives FDA Breakthrough Device Designation for Targeted Liquid Biopsy Test for Invasive Mold Infections

    Zepto Life Technology
    June 3, 2026
  • Zepto Life Technology Launches Plasma-Based FungiFlex® Mold Panel as CLIA Reference Laboratory Test

    Zepto Life Technology
    January 27, 2026